Left atrial appendage occlusion

Pilot study of a fourth-generation, minimally invasive device

Hideyuki Fumoto, A. Marc Gillinov, Roberto M. Saraiva, Tetsuya Horai, Tomohiro Anzai, Tohru Takaseya, Akira Shiose, Yoko Arakawa, D. Geoffrey Vince, Raymond Dessoffy, Kiyotaka Fukamachi

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

抄録

OBJECTIVE: Exclusion of the left atrial appendage is proposed to reduce the risk of stroke in patients with atrial fibrillation. The aim of this study was to evaluate the feasibility and efficacy of a fourth-generation atrial exclusion device developed for minimally invasive applications. METHODS: The novel atrial exclusion device consists of two polymer beams and two elastomeric bands that connect the two beams at either end. Fifteen mongrel dogs were implanted with the device at the base of the left atrial appendage through a median sternotomy and were evaluated at 30 (n = 7), 90 (n = 6), and 180 (n = 2) days after implantation by epicardial echocardiography, left atrial and coronary angiography, gross pathology, and histology. RESULTS: Left atrial appendage exclusion was completed without hemodynamic instability. Coronary angiography revealed that the left circumflex artery was patent in all cases. A new endothelial tissue layer developed, as expected, on the occluded orifice of the left atrium. CONCLUSIONS: This novel atrial exclusion device achieved easy, reliable, and safe exclusion of the left atrial appendage, with favorable histological results in a canine model for up to 6 months. Clinical application could provide a new therapeutic option for reducing the risk of stroke in patients with atrial fibrillation.

元の言語英語
ページ(範囲)195-200
ページ数6
ジャーナルInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
7
発行部数3
DOI
出版物ステータス出版済み - 5 1 2012

Fingerprint

Atrial Appendage
Equipment and Supplies
Coronary Angiography
Atrial Fibrillation
Stroke
Sternotomy
Heart Atria
Endothelium
Echocardiography
Canidae
Histology
Polymers
Arteries
Hemodynamics
Dogs
Pathology
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

これを引用

Left atrial appendage occlusion : Pilot study of a fourth-generation, minimally invasive device. / Fumoto, Hideyuki; Gillinov, A. Marc; Saraiva, Roberto M.; Horai, Tetsuya; Anzai, Tomohiro; Takaseya, Tohru; Shiose, Akira; Arakawa, Yoko; Vince, D. Geoffrey; Dessoffy, Raymond; Fukamachi, Kiyotaka.

:: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 巻 7, 番号 3, 01.05.2012, p. 195-200.

研究成果: ジャーナルへの寄稿記事

Fumoto, H, Gillinov, AM, Saraiva, RM, Horai, T, Anzai, T, Takaseya, T, Shiose, A, Arakawa, Y, Vince, DG, Dessoffy, R & Fukamachi, K 2012, 'Left atrial appendage occlusion: Pilot study of a fourth-generation, minimally invasive device', Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 巻. 7, 番号 3, pp. 195-200. https://doi.org/10.1097/IMI.0b013e3182618feb
Fumoto, Hideyuki ; Gillinov, A. Marc ; Saraiva, Roberto M. ; Horai, Tetsuya ; Anzai, Tomohiro ; Takaseya, Tohru ; Shiose, Akira ; Arakawa, Yoko ; Vince, D. Geoffrey ; Dessoffy, Raymond ; Fukamachi, Kiyotaka. / Left atrial appendage occlusion : Pilot study of a fourth-generation, minimally invasive device. :: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2012 ; 巻 7, 番号 3. pp. 195-200.
@article{ecb99ba0e9474547b81406a479c51e5e,
title = "Left atrial appendage occlusion: Pilot study of a fourth-generation, minimally invasive device",
abstract = "OBJECTIVE: Exclusion of the left atrial appendage is proposed to reduce the risk of stroke in patients with atrial fibrillation. The aim of this study was to evaluate the feasibility and efficacy of a fourth-generation atrial exclusion device developed for minimally invasive applications. METHODS: The novel atrial exclusion device consists of two polymer beams and two elastomeric bands that connect the two beams at either end. Fifteen mongrel dogs were implanted with the device at the base of the left atrial appendage through a median sternotomy and were evaluated at 30 (n = 7), 90 (n = 6), and 180 (n = 2) days after implantation by epicardial echocardiography, left atrial and coronary angiography, gross pathology, and histology. RESULTS: Left atrial appendage exclusion was completed without hemodynamic instability. Coronary angiography revealed that the left circumflex artery was patent in all cases. A new endothelial tissue layer developed, as expected, on the occluded orifice of the left atrium. CONCLUSIONS: This novel atrial exclusion device achieved easy, reliable, and safe exclusion of the left atrial appendage, with favorable histological results in a canine model for up to 6 months. Clinical application could provide a new therapeutic option for reducing the risk of stroke in patients with atrial fibrillation.",
author = "Hideyuki Fumoto and Gillinov, {A. Marc} and Saraiva, {Roberto M.} and Tetsuya Horai and Tomohiro Anzai and Tohru Takaseya and Akira Shiose and Yoko Arakawa and Vince, {D. Geoffrey} and Raymond Dessoffy and Kiyotaka Fukamachi",
year = "2012",
month = "5",
day = "1",
doi = "10.1097/IMI.0b013e3182618feb",
language = "English",
volume = "7",
pages = "195--200",
journal = "Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery",
issn = "1556-9845",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Left atrial appendage occlusion

T2 - Pilot study of a fourth-generation, minimally invasive device

AU - Fumoto, Hideyuki

AU - Gillinov, A. Marc

AU - Saraiva, Roberto M.

AU - Horai, Tetsuya

AU - Anzai, Tomohiro

AU - Takaseya, Tohru

AU - Shiose, Akira

AU - Arakawa, Yoko

AU - Vince, D. Geoffrey

AU - Dessoffy, Raymond

AU - Fukamachi, Kiyotaka

PY - 2012/5/1

Y1 - 2012/5/1

N2 - OBJECTIVE: Exclusion of the left atrial appendage is proposed to reduce the risk of stroke in patients with atrial fibrillation. The aim of this study was to evaluate the feasibility and efficacy of a fourth-generation atrial exclusion device developed for minimally invasive applications. METHODS: The novel atrial exclusion device consists of two polymer beams and two elastomeric bands that connect the two beams at either end. Fifteen mongrel dogs were implanted with the device at the base of the left atrial appendage through a median sternotomy and were evaluated at 30 (n = 7), 90 (n = 6), and 180 (n = 2) days after implantation by epicardial echocardiography, left atrial and coronary angiography, gross pathology, and histology. RESULTS: Left atrial appendage exclusion was completed without hemodynamic instability. Coronary angiography revealed that the left circumflex artery was patent in all cases. A new endothelial tissue layer developed, as expected, on the occluded orifice of the left atrium. CONCLUSIONS: This novel atrial exclusion device achieved easy, reliable, and safe exclusion of the left atrial appendage, with favorable histological results in a canine model for up to 6 months. Clinical application could provide a new therapeutic option for reducing the risk of stroke in patients with atrial fibrillation.

AB - OBJECTIVE: Exclusion of the left atrial appendage is proposed to reduce the risk of stroke in patients with atrial fibrillation. The aim of this study was to evaluate the feasibility and efficacy of a fourth-generation atrial exclusion device developed for minimally invasive applications. METHODS: The novel atrial exclusion device consists of two polymer beams and two elastomeric bands that connect the two beams at either end. Fifteen mongrel dogs were implanted with the device at the base of the left atrial appendage through a median sternotomy and were evaluated at 30 (n = 7), 90 (n = 6), and 180 (n = 2) days after implantation by epicardial echocardiography, left atrial and coronary angiography, gross pathology, and histology. RESULTS: Left atrial appendage exclusion was completed without hemodynamic instability. Coronary angiography revealed that the left circumflex artery was patent in all cases. A new endothelial tissue layer developed, as expected, on the occluded orifice of the left atrium. CONCLUSIONS: This novel atrial exclusion device achieved easy, reliable, and safe exclusion of the left atrial appendage, with favorable histological results in a canine model for up to 6 months. Clinical application could provide a new therapeutic option for reducing the risk of stroke in patients with atrial fibrillation.

UR - http://www.scopus.com/inward/record.url?scp=84865468429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865468429&partnerID=8YFLogxK

U2 - 10.1097/IMI.0b013e3182618feb

DO - 10.1097/IMI.0b013e3182618feb

M3 - Article

VL - 7

SP - 195

EP - 200

JO - Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

JF - Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

SN - 1556-9845

IS - 3

ER -